Role of nitric oxide in the development of corticotropin-induced hypertension in sheep

Clinical and Experimental Pharmacology and Physiology

Volumn 25, Issue 2, 1998, Pages 128-130

  Tresham, J J ^a   May, C N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Blood pressure; Corticotropin; L arginine; Nitric oxide; Sheep

Indexed keywords

ARGININE; CORTICOTROPIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; SHEEP;

EID: 0031932353     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1998.tb02189.x     Document Type: Article

References (18)

1. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988; 333: 664-6.
2. Elsner D, Muntze A, Kromer EP, Riegger GAJ. Inhibition of synthesis of endothelium-derived nitric oxide in conscious dogs. Am. J. Hypertens. 1992; 5: 288-91.
3. Tresham JJ, Dusting GJ, Coghlan JP, Whitworth JA. Haemodynamic and hormonal effects of N-nitro-L-arginine, an inhibitor of nitric oxide biosynthesis, in sheep. Clin. Exp. Pharmacol. Physiol. 1991; 18: 327-30.
4. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 1991; 88: 1559-67.
5. Hu L, Manning RD Jr. Role of nitric oxide in regulation of long term pressure natriuresis relationship in Dahl rats. Am. J. Physiol. 1995; 268: H2375-83.
6. Chen PY, Sanders PW. Role of nitric oxide in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22: 812-18.
7. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl Acad. Sci. USA 1990; 87: 10043-7.
8. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobioterin synthesis and L-arginine transport. J. Biol. Chem. 1996; 271: 23 928-37.
9. Laurant P, Demilombe B, Berthelot A. Dietary L-arginine attenuates blood pressure in mineralocorticoid-salt hypertensive rats. Clin. Exp. Hypertens. 1995; 17: 1009-24.
10. Turner SW, Wen C, Li M, Whitworth JA. L-Arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996; 27: 184-9.
11. Parkes DG, McDougall JG, Coghlan JP. ACTH-induced hypertension in sheep: An update. In: Ganten D, de Jong W (eds). Handbook of Hypertension, Vol. 16. Experimental and Genetic Models of Hypertension. Elsevier, Amsterdam. 1994; 581-605.
12. Li M, Dusting GJ, Whitworth JA. Inhibition of NO synthesis has an additive effect on hypertension induced by ACTH in conscious rats. Clin. Exp. Pharmacol. Physiol. 1992; 10: 675-81.
13. Bednarik JA, May CN. Differential regional hemodynamic effects of corticotropin in conscious sheep. Hypertension 1994; 24: 49-55.
14. G-nitro-L-arginine in the sheep. J. Cardiovasc. Pharmacol. 1994; 24: 144-50.
15. Ishii K, Chang B, Kerwin JF, Huang Z, Murad F. N-Nitro-L-arginine: A potent inhibitor of endothelium-derived relaxing factor formation. Eur. J. Pharmacol. 1990; 176: 219-23.
16. Pedrinelli R, Ebel M, Catapano G et al. Pressor, renal and endocrine effects of L-arginine in essential hypertensives. Eur. J. Clin. Pharmacol. 1995; 48: 195-201.
17. Gullino P, Winitz M, Birnbaum SM, Cornfield J, Otey MC, Greenstein JP. Toxicity of individual essential amino acids and their diastereomers in rats and the effect on blood sugar levels. Arch. Biochem. Biophys. 1955; 58: 253-5.
18. Weaver C, Bishop AE, Polak JM. Pancreatic changes elicited by chronic administration of excess L-arginine. Exp. Mol. Pathol. 1994; 60: 71-87.